Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells

International Journal of Molecular Medicine

Volumn 31, Issue 5, 2013, Pages 1202-1208

  Chang, Hyun ^a,c   Rha, Sun Young ^a,b,d   Jeung, Hei Cheul ^a,b,d   Park, Kyu Hyun ^b   Kim, Tae Soo ^b,d   Kim, Yong Bae ^b,e   Chung, Hyun Cheol ^a,b,d,f  

^a Division of Medical Oncology   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d National Biochip Research Center   (South Korea)

^e Department of Radiation Oncology ^*  (South Korea)

^f Yonsei University College of Medicine   (South Korea)

Author keywords

Angiogenesis; Endothelial cells; Genes; Radiation; Telomerase

Indexed keywords

BETA GALACTOSIDASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; HUMAN CELL; IRRADIATION; ONCOGENE C MYC; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SENESCENCE; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL AGING; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; RADIATION, IONIZING; TELOMERASE;

EID: 84876124574     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1300     Document Type: Article

References (31)

1. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z and Kolesnick R: Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300: 1155-1159, 2003.
2. Li J, Huang S, Armstrong EA, Fowler JF and Harari PM: Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade. Int J Radiat Oncol Biol Phys 62: 1477-1485, 2005.
3. Gunes C, Lichtsteiner S, Vasserot AP and Englert C: Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 60: 2116-2121, 2000.
4. Calado RT and Young NS: Telomere diseases. N Engl J Med 361: 2353-2365, 2009.
5. Grimes A and Chandra SB: Significance of cellular senescence in aging and cancer. Cancer Res Treat 41: 187-195, 2009.
6. Nakamura M, Masutomi K, Kyo S, Hashimoto M, Maida Y, Kanaya T, Tanaka M, Hahn WC and Inoue M: Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy. Hum Gene Ther 16: 859-868, 2005.
7. Pallini R, Pierconti F, Falchetti ML, D'Arcangelo D, Fernandez E, Maira G, D'Ambrosio E and Larocca LM: Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: Expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells. J Neurosurg 94: 961-971, 2001.
8. Falchetti ML, Mongiardi MP, Fiorenzo P, Petrucci G, Pierconti F, D'Agnano I, D'Alessandris G, Alessandri G, Gelati M, RicciVitiani L, Maira G, Larocca LM, Levi A and Pallini R: Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. Int J Cancer 122: 1236-1242, 2008.
9. Bu DX, Johansson ME, Ren J, Xu DW, Johnson FB, Edfeldt K and Yan ZQ: Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair. Arterioscler Thromb Vasc Biol 30: 2604-2610, 2010.
10. Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20: 4368-4380, 2002.
11. Damianovich D and Tebbutt NC: Role of novel targeted agents in the treatment of metastatic colorectal cancer. Asia Pac J Clin Oncol 3: 2-11, 2007.
12. Watanabe Y, Lee SW, Detmar M, Ajioka I and Dvorak HF: Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 14: 2025-2032, 1997.
13. Seegar TC, Eller B, Tzvetkova-Robev D, Kolev MV, Henderson SC, Nikolov DB and Barton WA: Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell 37: 643-655, 2010.
14. Kurz DJ, Hong Y, Trivier E, Huang HL, Decary S, Zang GH, Luscher TF and Erusalimsky JD: Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arterioscler Thromb Vasc Biol 23: 748-754, 2003.
15. Oliner J, Min H, Leal J, Yu D, Rao S, You E, Tang X, Kim H, Meyer S, Han SJ, Hawkins N, Rosenfeld R, Davy E, Graham K, Jacobsen F, Stevenson S, Ho J, Chen Q, Hartmann T, Michaels M, Kelley M, Li L, Sitney K, Martin F, Sun JR, Zhang N, Lu J, Estrada J, Kumar R, Coxon A, Kaufman S, Pretorius J, Scully S, Cattley R, Payton M, Coats S, Nguyen L, Desilva B, Ndifor A, Hayward I, Radinsky R, Boone T and Kendall R: Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 6: 507-516, 2004.
16. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B and Kinzler KW: Genes expressed in human tumor endothelium. Science 289: 1197-1202, 2000.
17. Kalluri R: Basement membranes: Structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433, 2003.
18. Durai R, Yang SY, Sales KM, Seifalian AM, Goldspink G and Winslet MC: Insulin-like growth factor binding protein-4 gene therapy increases apoptosis by altering Bcl-2 and Bax proteins and decreases angiogenesis in colorectal cancer. Int J Oncol 30: 883-888, 2007.
19. Roth JM, Akalu A, Zelmanovich A, Policarpio D, Ng B, MacDonald S, Formenti S, Liebes L and Brooks PC: Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo. Am J Pathol 166: 901-911, 2005.
20. Itasaka S, Komaki R, Herbst RS, Shibuya K, Shintani T, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK and O'Reilly MS: Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys 67: 870-878, 2007.
21. Ria R, Todoerti K, Berardi S, Coluccia AM, De Luisi A, Mattioli M, Ronchetti D, Morabito F, Guarini A, Petrucci MT, Dammacco F, Ribatti D, Neri A and Vacca A: Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma. Clin Cancer Res 15: 5369-5378, 2009.
22. Hong EH, Lee SJ, Kim JS, Lee KH, Um HD, Kim JH, Kim SJ, Kim JI and Hwang SG: Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase. J Biol Chem 285: 1283-1295, 2010.
23. Igarashi K, Sakimoto I, Kataoka K, Ohta K and Miura M: Radiation-induced senescence-like phenotype in proliferating and plateau-phase vascular endothelial cells. Exp Cell Res 313: 3326-3336, 2007.
24. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP and Jackson SP: A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194-198, 2003.
25. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
26. Takano H, Murasawa S and Asahara T: Functional and gene expression analysis of hTERT overexpressed endothelial cells. Biologics 2: 547-554, 2008.
27. Wu X, Smavadati S, Nordfjall K, Karlsson K, Qvarnstrom F, Simonsson M, Bergqvist M, Gryaznov S, Ekman S and PaulssonKarlsson Y: Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks. Biochim Biophys Acta 1823: 2130-2135, 2012.
28. Lin SY and Elledge SJ: Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113: 881-889, 2003.
29. Mezquita P, Parghi SS, Brandvold KA and Ruddell A: Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation. Oncogene 24: 889-901, 2005.
30. Zaccagnini G, Gaetano C, Della Pietra L, Nanni S, Grasselli A, Mangoni A, Benvenuto R, Fabrizi M, Truffa S, Germani A, Moretti F, Pontecorvi A, Sacchi A, Bacchetti S, Capogrossi MC and Farsetti A: Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J Biol Chem 280: 14790-14798, 2005.
31. Tian F, Liang PH and Li LY: Inhibition of endothelial progenitor cell differentiation by VEGI. Blood 113: 5352-5360, 2009.